Pharmacological interventions targeting β-adrenoceptors in colorectal cancer: an evolving paradigm
Inflammopharmacology · 2025
DOI: 10.1007/s10787-025-01925-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, 2025. Verfasst von Aya Ghosn und 5 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering, Newyork, NY, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Receptors, Adrenergic, beta, Adrenergic beta-Antagonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Qatar University.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a significant global health challenge, ranking as the third most common cancer and the second leading cause of cancer-related deaths worldwide. Its development is influenced by several risk factors, including smoking, diets rich in red meat, and the effects of stress-related hormones such as epinephrine and norepinephrine. These hormones act through β-adrenergic receptors (β-ARs), which are present on CRC cells and are associated with cancer-promoting processes such as increased cell growth, invasion, blood vessel formation, and accelerated disease progression. Notably, β-ARs blockers have shown potential in slowing CRC progression, pointing to a promising therapeutic strategy. This review explores the main signaling pathways through which β-ARs contribute to cancer development and how various risk factors may influence these mechanisms. We also provide an overview of current preclinical and clinical studies on β-AR blockers in CRC, identify existing gaps in knowledge, and propose directions for future research to optimize therapeutic outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Memorial Sloan Kettering, Newyork, NY, USA.
- Cleveland Clinic, Cleveland, OH, USA.
- Keele University, Staffordshire, UK.
- University of Sassari, Sassari, Italy.
- Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, PO Box 2713, Doha, Qatar. ali.eid@qu.edu.qa.
Förderung
- NCI NIH HHS
- Qatar University
Zitieren
APA
Ghosn, A., Bassam, K., Al Zein, M., Nasser, S. A., Pintus, G., & Eid, A. H. (2025). Pharmacological interventions targeting β-adrenoceptors in colorectal cancer: an evolving paradigm. Inflammopharmacology. https://doi.org/10.1007/s10787-025-01925-5
Vancouver
Ghosn A, Bassam K, Al Zein M, Nasser SA, Pintus G, Eid AH. Pharmacological interventions targeting β-adrenoceptors in colorectal cancer: an evolving paradigm. Inflammopharmacology. 2025. doi:10.1007/s10787-025-01925-5
BibTeX
@article{Ghosn2025,
author = {Ghosn, Aya and Bassam, Khalil and Al Zein, Mohammad and Nasser, Suzanne A and Pintus, Gianfranco and Eid, Ali H},
title = {Pharmacological interventions targeting β-adrenoceptors in colorectal cancer: an evolving paradigm},
journal = {Inflammopharmacology},
year = {2025},
doi = {10.1007/s10787-025-01925-5}
}
EUVIMED